Type
|
Public company |
---|---|
Traded as | CSIQ (NASDAQ) |
Industry | Renewable energy, Photovoltaics industry |
Founded | 2001 (2001) |
Founder | Dr. Shawn Qu, Chairman and CEO |
Headquarters | Guelph (Ontario), Canada |
Number of locations
|
Canada, Germany, Italy, Spain, South Africa, India, United Arab Emirates, Japan, Korea, Australia, the United States, Singapore, Hong Kong, China, Brazil, Panama, Turkey, United Kingdom, South Africa, Vietnam, Indonesia |
Products | Photovoltaic modules, Photovoltaic systems |
Revenue | $3.5 billion (USD, 2015) |
Number of employees
|
circa 9,000 |
Website | www |
Canadian Solar Inc. is a publicly traded company (NASDAQ: CSIQ) that manufactures solar PV modules and provides turn-key solar energy solutions.
Founded in 2001 in Canada by Dr. Shawn Qu, Canadian Solar (NASDAQ: CSIQ) operates as a global energy provider with business subsidiaries in over 24 countries on 6 continents. Besides serving as a manufacturer of solar PV modules and provider of solar energy solutions, Canadian Solar has a geographically diversified pipeline of utility-scale power projects. With the company’s recent acquisition of Recurrent Energy, Canadian Solar’s total project pipeline is now 20.4 GW, including an increase in the late-stage project pipeline to 2.4 GW. Including two state-of-the-art manufacturing facilities in Ontario, Canadian Solar employs nearly 9,000 workers worldwide. This translates to more than 16 GW of panel shipments, or approximately 70 million PV modules, in the past 15 years. Together with Recurrent Energy, Canadian Solar is ushering the way into a new era of clean, competitive, mainstream power.
Canadian Solar production facilities in Canada, China, Indonesia, Vietnam and Brazil are structured for the manufacturing of ingots, wafers, solar cells, solar PV modules, solar power systems and specialized solar products.
In 2008, Canadian Solar was one of the first module manufacturers to have an onsite ISO/IEC 17025-compliant testing laboratory. The Canadian Solar Photovoltaic Testing Lab was established to ensure compliance with international safety and reliability testing standards for solar panels.
The bulk of Canadian Solar's manufacturing facilities are located in Canada and China. The Ontario plant has a production capacity of over 500 MW per year. Canadian Solar passed the OHSAS 18001 international standards for occupational health and safety after auditing by TÜV Rheinland in 2012.
Below are some of Canadian Solar's worldwide project references:
Canadian Solar offers solar modules, solar power systems, off-grid solar home application systems and specialized solar products.
Canadian Solar's global PV project business unit has been in operation for over six years and develops PV projects worldwide, specializing in project development, system design, engineering and financing. In addition, Canadian Solar can handle the deployment of photovoltaic projects systems, ranging from commercial systems of a few hundred kilowatts to utility-scale projects measured in mega-watts.
Recurrent Energy: Canadian Solar (Nasdaq: CSIQ) completed the acquisition of solar developer Recurrent Energy from Sharp Corp for approximately $265 million in 2015.
Canadian Solar's standard modules are powered by 156 x 156 mm (6 inch) high efficiency mono-crystalline or poly-crystalline solar cells. Their new Dymond double-glass modules have better reliability and are PID-free; their five bus bar cells deliver higher module wattages and higher reliability.
Canadian Solar products adhere to international quality standards, including IEC 61215, IEC 61730, UL 1703, KEMCO, CE, JET CQC and MCS.
Canadian Solar modules have achieved the maximum ratings in tests for ammonia (NH3) resistance of solar modules and have also passed IEC 61701 salt mist resistance testing and are highly PID resistant.
Canadian Solar modules rank highly under PVUSA test conditions (PTC).
Canadian Solar modules passed blowing sand test according to IEC 60068-2-68 to determine the effects of dust and sand on electrotechnical products.
Canadian Solar was one of the first companies in the industry to offer enhanced product and performance warranty backed by an immediately available and non-cancellable insurance policy.
In 2011, Canadian Solar introduced a linear performance guarantee for PV module power output over a 25-year period. Under this policy, Canadian Solar expanded its product warranty covering workmanship and material defects up to 10 years.
Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-16 | Future report Set alerts | |
Q2 2022 | 2022-08-18 | 1.07 | 1.07 |
Q1 2022 | 2022-05-24 | 0.14 | 0.14 |
Q4 2021 | 2022-03-17 | 0.17 | 0.17 |
Q3 2021 | 2021-11-18 | 0.42 | 0.42 |
Q2 2021 | 2021-08-12 | 0.18 | 0.18 |
Q1 2021 | 2021-05-20 | 0.36 | 0.36 |
Q4 2020 | 2021-03-18 | 0.11 | 0.11 |
Q3 2020 | 2020-11-19 | 0.00 | 0.00 |
Q2 2020 | 2020-08-07 | 0.34 | 0.34 |
2016-06-29 | Reiterated Rating | Canaccord Genuity | Buy | $29.00 |
2016-06-27 | Reiterated Rating | FBR & Co. | Buy | $32.00 |
2016-06-27 | Reiterated Rating | FBR & Co | Buy | $32.00 |
2016-05-15 | Reiterated Rating | Roth Capital | Buy | $28.00 |
2016-05-14 | Reiterated Rating | Canaccord Genuity | Buy | $30.00 to $29.00 |
2016-05-12 | Reiterated Rating | FBR & Co. | Buy | |
2016-04-04 | Initiated Coverage | Barclays | Overweight | $24.00 |
2016-04-04 | Initiated Coverage | Barclays PLC | Overweight | $24.00 |
2016-03-31 | Reiterated Rating | Oppenheimer | Buy | $45.00 |
2016-03-31 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | $45.00 |
2016-03-29 | Reiterated Rating | Stifel Nicolaus | Buy | $28.00 |
2016-03-21 | Reiterated Rating | FBR & Co. | Outperform | $32.00 |
2016-03-19 | Reiterated Rating | Canaccord Genuity | Buy | $35.00 to $30.00 |
2016-03-16 | Lower Price Target | Cowen and Company | Outperform | $35.00 to $28.50 |
2016-03-16 | Initiated Coverage | Northland Securities | Outperform | $36.00 |
2016-03-15 | Reiterated Rating | Roth Capital | Buy | $40.00 to $28.00 |
2016-03-11 | Reiterated Rating | Stifel Nicolaus | Buy | $31.00 to $28.00 |
2016-03-10 | Reiterated Rating | FBR & Co. | Buy | $32.00 |
2016-02-26 | Downgrade | Standpoint Research | Buy | |
2016-02-21 | Reiterated Rating | FBR & Co. | Outperform | $32.00 |
2016-02-17 | Reiterated Rating | Roth Capital | Buy | $40.00 |
2016-02-17 | Reiterated Rating | Canaccord Genuity | Buy | $35.00 |
2016-02-02 | Reiterated Rating | Roth Capital | Buy | $40.00 |
2016-01-21 | Reiterated Rating | FBR & Co. | Buy | $32.00 |
2016-01-21 | Upgrade | Standpoint Research | Hold to Buy | $26.00 |
2015-12-30 | Reiterated Rating | Cowen and Company | Outperform | $28.50 to $35.00 |
2015-12-17 | Boost Price Target | Canaccord Genuity | Buy | $29.00 to $35.00 |
2015-12-17 | Initiated Coverage | FBR & Co. | Outperform | $32.00 |
2015-12-14 | Reiterated Rating | Roth Capital | Buy | $40.00 |
2015-11-25 | Downgrade | Standpoint Research | Buy to Hold | |
2015-11-13 | Reiterated Rating | Roth Capital | Buy | $40.00 |
2015-11-12 | Reiterated Rating | Canaccord Genuity | Buy | |
2015-11-10 | Initiated Coverage | Morgan Stanley | Overweight | $30.50 |
2015-10-27 | Reiterated Rating | Canaccord Genuity | Buy | $40.00 to $29.00 |
2015-10-26 | Reiterated Rating | Cowen and Company | Outperform | $28.50 |
2015-10-09 | Reiterated Rating | Roth Capital | Buy | |
2015-09-24 | Initiated Coverage | Stifel Nicolaus | Buy | $25.00 |
2015-09-08 | Initiated Coverage | Oppenheimer | Outperform | $43.00 |
2015-08-25 | Initiated Coverage | Cowen and Company | Outperform | $28.50 |
2015-08-21 | Upgrade | Standpoint Research | Hold to Buy | $26.00 |
2015-08-19 | Lower Price Target | Canaccord Genuity | Buy | $45.00 to $40.00 |
2015-08-19 | Lower Price Target | Roth Capital | Buy | $46.00 to $40.00 |
2015-08-17 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $39.00 to $36.00 |
2015-06-01 | Reiterated Rating | FBR & Co. | Outperform | $45.00 |
2015-05-19 | Boost Price Target | Roth Capital | $46.00 | |
2015-05-19 | Reiterated Rating | Canaccord Genuity | Buy | $45.00 |
2015-05-18 | Reiterated Rating | Roth Capital | Buy | $40.00 to $40.00 |
2015-05-08 | Set Price Target | Roth Capital | Buy | $40.00 |
2015-04-07 | Lower Price Target | Canaccord Genuity | Positive to Buy | $46.00 to $45.00 |
2015-03-06 | Downgrade | Standpoint Research | Buy to Hold | |
2015-03-06 | Upgrade | Goldman Sachs | Neutral to Buy | |
2015-03-06 | Upgrade | Goldman Sachs Group Inc. | Neutral to Buy | |
2015-01-13 | Initiated Coverage | CICC Research | Buy | |
2014-11-18 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $38.00 to $36.00 |
2014-11-18 | Initiated Coverage | Standpoint Research | Buy | $36.00 |
2014-11-13 | Reiterated | Northland Capital | Outperform | $47 to $48 |
2014-11-13 | Lower Price Target | Canaccord Genuity | Buy | $48.00 to $46.00 |
2014-11-13 | Boost Price Target | Northland Securities | Outperform | $47.00 to $48.00 |
2014-10-14 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $43.50 to $41.00 |
2014-09-23 | Boost Price Target | Canaccord Genuity | Buy | $44.00 to $48.00 |
2014-09-17 | Reiterated | FBR Capital | Outperform | $40 to $45 |
2014-09-17 | Boost Price Target | FBR & Co. | Outperform | $40.00 to $45.00 |
2014-08-14 | Boost Price Target | Roth Capital | Buy | $35.00 to $40.00 |
2014-07-15 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $41.00 to $43.50 |
2014-07-07 | Upgrade | FBR Capital | Mkt Perform to Outperform | $40 to $40 |
2014-07-07 | Upgrade | FBR & Co. | Market Perform to Outperform | $40.00 |
2014-07-02 | Initiated Coverage | Canaccord Genuity | Buy | $43.00 |
2014-05-20 | Reiterated Rating | Nomura | Buy | $55.00 to $45.00 |
2014-05-19 | Reiterated | Northland Capital | Outperform | $52 to $46 |
2014-05-19 | Lower Price Target | Northland Securities | Outperform | $52.00 to $46.00 |
2014-05-16 | Lower Price Target | Roth Capital | $50.00 to $35.00 | |
2014-03-11 | Initiated Coverage | Dougherty & Co | Buy | |
2014-03-07 | Initiated Coverage | Goldman Sachs | Neutral | |
2014-03-06 | Reiterated | Northland Capital | Outperform | $51 to $52 |
2014-03-04 | Reiterated | Northland Capital | Outperform | $40 to $51 |
2014-03-04 | Boost Price Target | Northland Securities | Outperform | $40.00 to $51.00 |
2014-02-24 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $50.00 |
2014-02-19 | Initiated Coverage | FBR & Co. | Market Perform | |
2014-01-29 | Boost Price Target | Roth Capital | $50.00 | |
2013-11-14 | Reiterated | Northland Capital | Outperform | $26 to $40 |
2013-11-14 | Boost Price Target | Northland Securities | Outperform | $26.00 to $40.00 |
2013-10-25 | Boost Price Target | Lazard Capital Markets | Buy | $25.00 to $35.00 |
2013-10-08 | Initiated Coverage | Northland Securities | Outperform | $26.00 |
2013-10-03 | Boost Price Target | Lazard Capital Markets | Buy | $20.00 to $25.00 |
2013-09-20 | Boost Price Target | Lazard Capital Markets | Buy | $18.00 to $20.00 |
2013-05-29 | Reiterated | Maxim Group | Buy | $10 to $12 |
2013-05-28 | Reiterated | Maxim Group | Buy | $10 to $12 |
2012-07-18 | Upgrade | Avian | Neutral to Positive | |
2011-04-15 | Reiterated | Auriga U.S.A | Buy | $20 to $18 |
2011-03-31 | Initiated | Brean Murray | Hold | |
2011-03-14 | Reiterated | Collins Stewart | Hold | $13.80 to $9 |
2011-01-11 | Upgrade | Auriga U.S.A | Hold to Buy | $13 to $20 |
2010-11-19 | Reiterated | Wedbush | Neutral | $12 to $14 |
2010-10-20 | Reiterated | Deutsche Bank | Hold | $11 to $12 |
2010-10-08 | Reiterated | Oppenheimer | Perform | $12 to $16 |
2010-09-02 | Reiterated | Wedbush | Neutral | $11 to $12 |
2010-08-20 | Reiterated | Oppenheimer | Perform | $10 to $12 |
2010-07-14 | Initiated | Jefferies | Hold | $11 |
2016-06-29 | Reiterated Rating | Canaccord Genuity | Buy | $29.00 |
2016-06-27 | Reiterated Rating | FBR & Co. | Buy | $32.00 |
2016-06-27 | Reiterated Rating | FBR & Co | Buy | $32.00 |
2016-05-15 | Reiterated Rating | Roth Capital | Buy | $28.00 |
2016-05-14 | Reiterated Rating | Canaccord Genuity | Buy | $30.00 to $29.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CSIQ 135 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 4.62M |
Grantham, Mayo, Van Otterloo & Co. LLC | 3.69M |
Invesco Ltd. | 2.52M |
SCHRODER INVESTMENT MANAGEMENT GROUP | 2.39M |
MACKENZIE FINANCIAL CORP | 1.96M |
Vanguard Group, Inc | 1.91M |
CITADEL ADVISORS LLC | 1.89M |
BlackRock Group LTD | 1.57M |
Pomelo Capital LLC | 1.22M |
Guinness Asset Management LTD | 0.88M |
Walleye Trading LLC | 0.79M |
RHJ International SA | 0.64M |
MORGAN STANLEY | 0.54M |
DnB Asset Management AS | 0.54M |
D. E. Shaw & Co., Inc. | 0.54M |